0001209191-19-003938.txt : 20190116
0001209191-19-003938.hdr.sgml : 20190116
20190116163123
ACCESSION NUMBER: 0001209191-19-003938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190114
FILED AS OF DATE: 20190116
DATE AS OF CHANGE: 20190116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danziger Asaf
CENTRAL INDEX KEY: 0001654435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 19529340
MAIL ADDRESS:
STREET 1: 5 NACHUM CHAT ST.
CITY: TIRAT HACARMEL
STATE: L3
ZIP: 5112302
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-14
0
0001645113
NovoCure Ltd
NVCR
0001654435
Danziger Asaf
C/O NOVOCURE INC.
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
1
1
0
0
Chief Executive Officer
Ordinary Shares
2019-01-14
4
M
0
100000
3.44
A
271164
D
Ordinary Shares
2019-01-14
4
S
0
100000
43.524
D
171164
D
Ordinary Shares
2019-01-15
4
M
0
100000
3.44
A
271164
D
Ordinary Shares
2019-01-15
4
S
0
100000
43.488
D
171164
D
Options to Buy Ordinary Shares
3.44
2019-01-14
4
M
0
100000
0.00
D
2021-12-13
Ordinary Shares
100000
346863
D
Options to Buy Ordinary Shares
3.44
2019-01-15
4
M
0
100000
0.00
D
2021-12-13
Ordinary Shares
100000
246863
D
These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.
On January 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 100,000 shares in multiple trades at prices ranging from $43.44 to $43.66. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On January 15, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 100,000 shares in multiple trades at prices ranging from $43.44 to $43.92. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested and currently exercisable as of the date hereof.
By: /s/ Kimberly Burke, Attorney in fact for Asaf Danziger
2019-01-16